Before she finally had successful treatment for her Clostridioides difficile infection in New Haven, Connecticut, Freda Pyles’ family physician in rural Pennsylvania was terrified and frustrated that he could not cure her and other patients.
Freda Pyles’ family physician in rural Pennsylvania was terrified and frustrated that he could not make her and other patients recover from their Clostridioides difficile infections. Pyles was later treated successfully in New Haven, Connecticut, through a fecal transplant.
Transcript
As a patient who had Clostridioides difficile, how did only having access to rural health care affect how you dealt with things—was that an issue?
It was, but my family physician here—he had never seen anybody as bad as me. But he had 3 patients in the nursing home, they had C diff at the same time. And he was just so frustrated with what he could do for them. And he's just over the moon happy about my success with it. He can't tell enough people about it…he saw me suffer. One day, I went in there for, I don't even remember which complaint it was. But he just came over and he hugged me, because I think he thought I was dying too. I think he watched me deteriorate so much that he was really nervous, because he knows my husband and he knows me—he's known us for many years. So he was really struggling with it too. But he was really good. I just can't say enough about how careful he was—he kept reminding me that I needed to be careful because it's contagious.
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More